24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Can the pharmaceutical industry help to advance the model for publishing of scientific research? This question has assumed greater importance as other funders have started to flex their muscles, introducing open access policies and even their own publishing platforms (e.g. Royal Society Open Science, Wellcome Open Research), but stringent regulation and widespread mistrust of open…
A group of budding knitters from the Oxford PharmaGenesis Oxford office answered the plea from Innocent to create knitted hats for their smoothie drinks by knitting more than 80 amazing hats!
With a company stand and a high level of participation in the programme, Oxford PharmaGenesis made a significant contribution to the European Meeting of the International Society for Medical Publication Professionals (ISMPP) held in London last week.
It was a cold Thursday evening but that did not stop the MedComms business community coming out to celebrate 10 years of MedComms Networking at an event organized by Peter Llewellyn – and the Oxford PharmaGenesis team were well represented!
London, UK, 17 January 2017 – The American Medical Writers Association (AMWA), European Medical Writers Association (EMWA), and International Society for Medical Publication Professionals (ISMPP) today released a Joint Position Statement on the Role of Professional Medical Writers, which is the first unified position on the role of professional medical writers from three leading professional…
The expertise of Oxford PharmaGenesis in planning and communicating real-world evidence (RWE) was showcased in a leader published online this month by eyeforpharma.
